Historical record - last NADAC publication: 11/20/2019
Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1835 per EA under NDC 27241002050. Its NADAC has been published 133 times since May 24, 2017.
Strength
30 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241002050
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
11/20/2019
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203957On Market Since
10/18/2016
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 133 times since May 24, 2017, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1835 per EA |
|---|---|
| All-time high | $0.2784 (Jul 12, 2017) |
| All-time low | $0.1605 (Aug 21, 2019) |
| Median price | $0.1958 |
| Average price | $0.2065 |
| Largest weekly change | -14.2% (Nov 21, 2018) |
| Weeks tracked | 133 |
| Tracking since | May 24, 2017 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.1835 per EA (NDC 27241002050), effective Dec 4, 2019.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 32.5%. It has been tracked across 133 weekly CMS publications since May 24, 2017.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since May 24, 2017, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.1605 (Aug 21, 2019) to a high of $0.2784 (Jul 12, 2017), with a median of $0.1958 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LANSOPRAZOLE DR 30 MG CAPSULE, is $0.1067 per EA — about 42% below LANSOPRAZOLE DR 30 MG CAPSULE.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 27241002050) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification